US2007135641A1PendingUtilityA1
Synthesis
Est. expirySep 9, 2023(expired)· nominal 20-yr term from priority
A61P 25/02C07C 231/12A61P 1/10C07D 471/08A61P 1/06A61P 1/00A61P 1/04
44
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present invention provides an improved process for the production of [(±)-endo]-4-amino-5-chloro-2-methoxy-N-(1-azabicyclo[3.3.1 ]non-4-yl)benzamide hydrochloride, compositions thereof, and intermediates thereto.
Claims
exact text as granted — not AI-modified1 - 6 . (canceled)
7 . A process for the preparation of compound (14) from compound (7)
comprising decomplexation of the amine of compound (7) by reflux in toluene followed by azeotropic drying of the produced compound (14).
8 . A process for the preparation of compound (7) from compound (6)
comprising reacting compound (6) with sodium followed by reaction with carbon dioxide characterised in that the reaction of compound (6) with sodium is carried out in butanol.
9 . A compound of formula (7)
10 . A process for the formation of compound (6) from compound (5)
comprising formation of oxime (6) from compound (5) by the reverse addition of compound (5) in butanol to a slurry of hydroxylamine hydrochloride.
11 . A process for the preparation of compound (5) from ethyl nipecotate comprising:
1) production of compound (3) from ethyl nipecotate by reaction of ethyl nipecotate with ethyl acrylate 2) production of compound (4) from compound (3) by reflux of compound (3) with base; and 3) formation of compound (5) from compound (4) by reaction of compound (4) with aqueous HCl followed by sodium hydroxide.
12 . A process as claimed in claim 11 wherein the reaction of ethyl nipecotate and ethyl acrylate is carried out in toluene and compound (3) is reacted with tBuOK.
13 . A process for the preparation of acid (11) from compound (10)
by the addition of aqueous sodium hydroxide to a slurry of compound (10) in water, followed by precipitation of acid ( 11) by the addition of hydrochloric acid.
14 . A process for the preparation of acid (16):
from compound (10): by reaction with aqueous potassium hydroxide and ethanol followed by the addition of hydrochloric acid.
15 . A process for the preparation of amine (14) from ethyl nipecotate comprising a) formation of compound (5) as claimed in claim 11 and b) conversion of compound (5) to amine (14) comprising:
1) formation of oxime (6) from compound (5) by the reverse addition of compound (5) in butanol to a slurry of hydroxylamine hydrochloride; 2) reacting compound (6) with sodium followed by reaction with carbon dioxide characterised in that the reaction of compound (6) with sodium is carried out in butanol; and 3) decomplexation of the amine of compound (7) by reflux in toluene followed by azeotropic drying of the produced compound (14).
16 - 20 . (canceled)
21 . A compound of formula (8)
produced by the process comprising
1) preparing acid chloride (13) from acid (11)
by reacting acid ( 11) with oxalyl chloride or thionyl chloride in dichloromethane, toluene, dimethylformamide (DMF) or tetrahydrofuran (THF)
2) reacting the acid chloride (13) in toluene with amine (14)
and isolating the product (8) therefrom.
22 . A compound of formula (9)
produced from acid 16 and amine (14)
by a process comprising reacting the acid (16) with DMF, triethylamine and ethyl chloroformate then reacting the in situ acid chloride with amine (14) in toluene.
23 . A compound of formula (14) as produced by the process of claim 7
24 . A compound of formula (5) as produced by the process of claim 11
25 . A compound of formula (11) as produced by the process of claim 13
26 . A compound of formula (16) as produced by the process of claim 14
27 . A pharmaceutical composition comprising a compound of formula (9), according to claim 22 , or the hydrochloride salt thereof and a pharmaceutically acceptable excipient
28 . A method of treating a disorder relating to impaired gastro-intestinal motility comprising administering to a subject in need thereof a compound of formula (9), according to claim 22 ,
29 . A method as claimed in claim 28 wherein the disorder is one or more of irritable bowel syndrome, retarded or delayed gastric emptying, dyspepsia, oesophageal reflux, peptic ulcer, flatulence, impaired evacuation, constipation, diabetic neuropathy, functional abdominal bloating or abdominal pain.
30 . A compound as claimed in claim 21 wherein the preparation of the acid chloride (13) is carried out by reacting acid (11) with DMF and thionyl chloride in the presence of THF, wherein the DMF is added to the acid prior to the thionyl chloride and carrying out a solvent exchange with toluene prior to the reaction of the acid chloride with amine (14).
31 . A process as claimed in claim 22 , wherein acid (16) is produced by the process as claimed in claim 14Join the waitlist — get patent alerts
Track US2007135641A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.